,outcome,arm 1,arm 2
0,intervention,amantadine-treated group,
0,"absolute changes in clinician-rated ABC-CVs for hyperactivity, inappropriate speech",-1.9,0.4
0,"absolute changes in clinician-rated ABC-CVs for hyperactivity, total study group","amantadine -6.4 versus, placebo -2.1 ;","amantadine -6.4 versus, placebo -2.1 ;"
